$CL

This Dividend King Was Removed From the S&P 100. Here's Why It's a Great Buy for Long-Term Investors Anyway.

Colgate-Palmolive (CL) was removed from the S&P 100 due to its $69B market cap being too small, but remains in the S&P 500. The company has raised dividends for 63 years and analysts expect 17% EPS growth from 2025-2028, with a current yield of 2.4%.

Original reporting
Published Sep 23, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This Dividend King Was Removed From the S&P 100. Here's Why It's a Great Buy for Long-Term Investors Anyway. — source image
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

For traders, the key is whether index-tracking demand changes meaningfully. The article suggests the impact is mostly confined to smaller S&P 100 ETFs (e.g., OEF) rather than the broader S&P 500 passive complex.

02

Market read

This is an index-constituent and passive-flow story, not a new earnings or guidance catalyst.

03

What to watch

The article does not quantify expected fund-flow changes, and it leans on analyst EPS/dividend projections that may not materialize.

Relevance 4/10Novelty 3/10Timing: post Sept. 21 S&P 100 rebalancing

Background

The piece explains that S&P Global removed CL from the S&P 100 during quarterly rebalancing because its market cap was too small, while CL remains in the S&P 500.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Colgate-Palmolive (CL) was removed from the S&P 100 in S&P Global’s Sept. 21 quarterly rebalancing due to market-cap size.

Expected impact

Low near-term impact; any effect should be limited to ETF/index-tracking flow mechanics rather than earnings power.

Evidence & confidence

The article states CL remains in the S&P 500, implying continued broad passive ownership, with only reduced exposure to smaller S&P 100-focused ETFs.

Market effects

Consumer staples names may see periodic index-constituent churn, but this specific event is framed as valuation-driven versus fundamentals.

Primarily US passive-flow mechanics tied to S&P index products.

Limited; the story is about US index construction and passive investing rather than global demand or regulation.

Counterpoint

Removal from the S&P 100 could still matter for liquidity and marginal demand from S&P 100-tracking funds, even if CL stays in the S&P 500.

Key entities

  • Colgate-Palmolive

    Removed from the S&P 100 on Sept. 21 but remains in the S&P 500; article argues dividend growth outlook remains intact.

  • S&P Global

    Conducted the quarterly rebalancing that removed CL from the S&P 100.

  • iShares S&P 100 ETF (OEF)

    Example of an S&P 100-linked ETF that would lose CL exposure after the rebalancing.

Related articles

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

$CLMedAI 8/10

Colgate-Palmolive reportedly weighs US$1B personal care offload.

Colgate-Palmolive is reportedly considering the sale of select mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, for over $1 billion. The company is working with Goldman Sachs on the potential divestment to focus on higher-margin businesses amid North American competition. Personal care accounted for 17% of its 2025 net sales of $20.38 billion.

$CLMed

CL Stock Alert: Colgate-Palmolive Reportedly Considers $1 Billion Brand Sale

Colgate-Palmolive (CL) is reportedly exploring the sale of non-core personal care brands, valued at over $1 billion, with Goldman Sachs' advisory. The move aims to reallocate capital toward higher-growth segments. CL shares are down 12% year-to-date, trading below major moving averages, but offer a 2.44% dividend yield. Institutional investors remain bullish, and the consensus rating is 'Moderate Buy' with a mean price target of $160.

$CLMedAI 8/10

Colgate-Palmolive Seeks Value Through Portfolio Reshaping

Colgate-Palmolive (NYSE:CL) is exploring the sale of mass-market personal care brands, including Softsoap, Irish Spring, and Speed Stick, potentially generating over $1 billion. The move aims to simplify its portfolio and focus on higher-growth areas like oral care and pet nutrition, amid competitive pressure in North America. The company reported a 4.9% increase in net sales, but organic sales in North America declined 3%. Proceeds could be used for debt reduction, share repurchases, or acquisi